Fig. 1

Plasma FXa in Ren-Tg and WT mice after 4 weeks of treatment with or without Riv (n  =  3–6). Comparisons were made by two-way ANOVA followed by Tukey’s post hoc test. FXa indicates factor Xa, Ren-Tg renin-overexpressing hypertensive transgenic, WT wild-type, Riv rivaroxaban